Literature DB >> 15321899

Fatal liver failure associated with pioglitazone.

Ed Farley-Hills1, R Sivasankar, M Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15321899      PMCID： PMC514204          DOI： 10.1136/bmj.329.7463.429

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Pioglitazone-associated fulminant hepatic failure.

Authors:  Michael P Chase; Joseph C Yarze
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

Review 2.  Hepatotoxicity with thiazolidinediones: is it a class effect?

Authors:  A J Scheen
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  Hepatotoxicity of the thiazolidinediones.

Authors:  Keith G Tolman; Jane Chandramouli
Journal:  Clin Liver Dis       Date:  2003-05       Impact factor: 6.126

Review 4.  Hepatotoxicity of thiazolidinediones.

Authors:  William L Isley
Journal:  Expert Opin Drug Saf       Date:  2003-11       Impact factor: 4.250
  4 in total
  9 in total

Review 1.  Pioglitazone: a review of its use in type 2 diabetes mellitus.

Authors:  John Waugh; Gillian M Keating; Greg L Plosker; Stephanie Easthope; Dean M Robinson
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Liver toxicity and pioglitazone: data are missing.

Authors:  Peshraw Amin
Journal:  BMJ       Date:  2004-10-16

3.  Prediction of drug-induced liver injury using keratinocytes.

Authors:  Rika Hirashima; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  J Appl Toxicol       Date:  2017-01-31       Impact factor: 3.446

4.  Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cells.

Authors:  Lei Guo; Lu Zhang; Yongming Sun; Levan Muskhelishvili; Ernice Blann; Stacey Dial; Leming Shi; Gary Schroth; Yvonne P Dragan
Journal:  Mol Divers       Date:  2006-09-21       Impact factor: 2.943

5.  Drug-induced Liver Injury.

Authors:  Stefan David; James P Hamilton
Journal:  US Gastroenterol Hepatol Rev       Date:  2010-01-01

Review 6.  Drug Interactions of Clinical Importance with Antihyperglycaemic Agents : An Update.

Authors:  André J Scheen
Journal:  Drug Saf       Date:  2005-07       Impact factor: 5.606

7.  Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England.

Authors:  Rachna Kasliwal; Lynda V Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 8.  Pioglitazone for type 2 diabetes mellitus.

Authors:  B Richter; E Bandeira-Echtler; K Bergerhoff; C Clar; S H Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

9.  Toxicological evaluation of subchronic use of pioglitazone in mice.

Authors:  Said Said Elshama; Ayman El-Meghawry El-Kenawy; Hosam-Eldin Hussein Osman
Journal:  Iran J Basic Med Sci       Date:  2016-07       Impact factor: 2.699
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.